NCT00442845
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Brain Diseases, +23 more
- Locations
-
- Pfizer Investigational Site Mississauga, Ontario, Cameroon
- Pfizer Investigational Site Calgary, Alberta, Canada
- Pfizer Investigational Site Edmonton, Alberta, Canada
- Pfizer Investigational Site Medicine Hat, Alberta, Canada